BioSpace News Archive

9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced that the Company’s CEO, John Temperato will be participating in Citi’s 16th Annual BioPharma Virtual Conference taking place between September 8th-10th and invites investors to join virtually.

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that Christian Albrich has been appointed as Chief People Officer of the Company.

Evoke Pharma, Inc. today announced that Dave Gonyer R.Ph., President and Chief Executive Officer, and Matt D’Onofrio, Chief Business Officer, will participate virtually in the H.C. Wainwright 23rd Annual Global Investment Conference taking place from September 13 – 15, 2021.

Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer, announced the appointment of Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs.

The U.S. Food and Drug Administration has provided 510 (k) Clearance for Prelivia, a neurostimulation device developed by Rehabtronics that promotes healthy blood circulation and maintains healthy tissue in people who are bedridden or chair bound.

Rubius Therapeutics, Inc. (Nasdaq: RUBY), today announced that the Company’s executive management team will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 9-13, 2021,and the H.C. Wainwright 23rd Annual Global Investment Conference on September 14, 2021.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of two significant new technologies to its total knee arthroplasty (TKA) portfolio - the JOURNEY II Medial Dished (MD) for TKA and SYNC Performance Instruments.

OrthogenRx®, Inc., a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions, including osteoarthritis, announced it will showcase its new platform HARMOKNEE™ Customer Support Services, at the 2021 American Academy of Orthopaedic Surgeons Annual Meeting in San Diego, CA August 31- September 3, 2021.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced Karim Chamie, M.D., Associate Professor of Urology, UCLA Department of Urology, will be presenting the Phase 2/3 clinical results of IL-15 Superagonist N-803 with BCG in BCG-unresponsive bladder cancer at the American Urological Association’s Annual Meeting on Sept. 10th.

Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its Artificial Intelligence (AI)-driven HART CADhs blood test is more accurate than high sensitivity troponin in determining whether a patient has obstructive heart disease.